USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Read the full report on Pharmtech
Story file
How this page works. The Headline Update lists this report from Pharmtech with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
